Clinicians are using AI to summarize evidence, support decision-making, surface insights, and accelerate workflows. For many healthcare organizations, the question is no longer whether AI has a role to play. It’s how to scale its use safely, responsibly, and effectively.
But what happens when the answer isn’t straightforward?
Two guidelines conflict. The evidence changed last month. The patient has renal impairment. A citation technically supports the sentence but not the clinical conclusion. Multiple clinically acceptable approaches exist, yet the AI presents only one answer.
These are just some of the situations clinical AI governance will increasingly need to address. That is where governance becomes real.
As healthcare leaders evaluate and implement AI, governance is often viewed as a necessary safeguard. Yet the most successful organizations are beginning to see governance differently: not as a barrier to innovation, but as the mechanism that makes innovation possible.
In our upcoming whitepaper, we explore five questions healthcare leaders should ask as AI becomes more deeply embedded in clinical workflows. Drawing on emerging research and real-world governance challenges, the paper examines how health systems can move beyond viewing governance as a checkpoint and instead treat it as infrastructure for responsible scale.
The paper explores:
These are not simply controls placed around innovation. They are part of the infrastructure required to scale it.
The health systems that succeed with clinical AI may not be those that adopt the most tools or move the fastest. They will be those that develop the governance capabilities to distinguish where AI can create meaningful clinical and operational value, where additional safeguards are necessary, and where the technology is not yet ready.
Governance, in that sense, is not the opposite of innovation.
It is what allows innovation to move from promising technology to trusted clinical infrastructure.
Check back soon for the full paper to dive deeper into the five essential questions that can help healthcare organizations scale AI responsibly while maintaining trust, transparency and clinical accountability.
Full paper coming soon.